ISSN 2347-954X (Print) Research Article. *Corresponding author Dr. Abhijeet A. Adgaonkar Email:



Similar documents
WHEN TO ORDER; HOW TO INTERPRET

DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa

Diabetes : Foot Education

ELECTROMYOGRAPHY (EMG), NEEDLE, NERVE CONDUCTION STUDIES (NCS) AND QUANTITATIVE SENSORY TESTING (QST)

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Diabetes Mellitus Type 2

Diabetes Fundamentals

Post-Transplant Diabetes: What Every Patient Needs to Know

Welcome to Diabetes Education! Why Should I Take Control of My Diabetes?

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Podiatric Surgeon s Primer on Thyroid Pathology and Entrapment Neuropathies

How To Know If You Have Microalbuminuria

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat?

Baskets of Care Diabetes Subcommittee

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

EMG and the Electrodiagnostic Consultation for the Family Physician

Statistics of Type 2 Diabetes

Aetna Nerve Conduction Study Policy

Diabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes.

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

CHPN Review Course Pain Management Part 1 Hospice and Palliative Nurses Association

Kansas Behavioral Health Risk Bulletin

Causes, incidence, and risk factors

Type 1 Diabetes ( Juvenile Diabetes)

6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S.

How can DIABETES affect my FEET? Emma Howard Community Diabetes Lead Podiatrist, Oxford Health NHS Foundation Trust

CERVICAL DISC HERNIATION

Spinal Cord Stimulation (SCS) Therapy: Fact Sheet

DIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care

Diabetes mellitus. Lecture Outline

Group Benefits Evidence of Insurability for Comprehensive Optional Critical Illness Insurance

Symptoms and Signs of Irritation of the Brachial Plexus in Whiplash Injuries

Diabetes. Patient Education. What you need to know. Diabetes Facts. Improving Health Through Education. What is Diabetes?

Diabetes Complications

Part B: 3 3. DIABETES MELLITUS Effects of diabetes on driving Evidence of crash risk Hypoglycaemia

DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria

3nd Biennial Contemporary Clinical Neurophysiological Symposium October 12, 2013 Fundamentals of NCS and NMJ Testing

A Fuzzy Logic Based Model for Life Insurance Underwriting When Insurer Is Diabetic

Multifocal Motor Neuropathy. Jonathan Katz, MD Richard Lewis, MD

Module 1: The Somato-Motor System: Tendon Tap reflex

How To Determine The Prevalence Of Microalbuminuria

WHAT IS DIABETES MELLITUS? CAUSES AND CONSEQUENCES. Living your life as normal as possible

Markham Stouffville Hospital

Background (cont) World Health Organisation (WHO) and IDF predict that this number will increase to more than 1,3 million in the next 25 years.

The Family Library. Understanding Diabetes

Assessment of spinal anaesthetic block

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

Type 2 diabetes Definition

Medical Treatment Guidelines Washington State Department of Labor and Industries

2012 Georgia Diabetes Burden Report: An Overview

Borgess Diabetes Center PATIENT REGISTRATION/DEMOGRAPHICS

Management of Diabetes Mellitus among Elderly Men and Women Impact of Intervention Programme

Diabetes Questionnaire

Title of dissertation. RONPAKU Fellow Name

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

Closed Automobile Insurance Third Party Liability Bodily Injury Claim Study in Ontario

Return to same game if sx s resolve within 15 minutes. Return to next game if sx s resolve within one week Return to Competition

Life Insurance Application Form

Ms. Jackson is the Manager of Health Finance and Reimbursement, Division of Health Policy and Practice Services, Washington, DC.

N E B R A S K A JAIL BULLETIN NUMBER 102 OCTOBER 1993

a) Nerve conduction studies (NCS) test the peripheral nervous system for:

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE

Healthy at Heart FEELING GOOD. Reduce Your CV Risk. It s Not Just Your Body. It s Your Outlook, Too. Issue 3

Things You Don t Want to Miss in Multiple Myeloma

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

Medicare Podiatry Services: Information for Medicare Fee-For-Service Health Care Professionals

CLINICAL PRACTICE GUIDELINES FOR MANAGEMENT OF LOW BACK PAIN

Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge

8 th Annual W/C Spine Summit. Ted A. Lennard, MD Feb. 12, 2015

MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol)

Understanding. Peripheral Neuropathy. Lois, diagnosed in 1998, with her husband, Myron.

International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014

THE PRAKASAM DISTRICT DIABETES PREVENTION PROGRAM. Booklet on Diabetes. Supported by World Diabetes Foundation

Efficacy of Short-term Low Dose Oral Steroid in Carpal Tunnel Syndrome

Electrodiagnostic Testing

Modifiers Q7, Q8, and Q9

06/06/2012. The Impact of Multiple Sclerosis in the Pacific Northwest. James Bowen, MD. Swedish Neuroscience Institute

Impact of adhesive capsulitis on quality of life in elderly subjects with diabetes: A cross sectional study

Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Role of Electrodiagnostic Tests in Neuromuscular Disease

Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas

Teriflunomide (Aubagio) 14mg once daily tablet

Robert Okwemba, BSPHS, Pharm.D Philadelphia College of Pharmacy

LUMBAR. Hips R L B R L B LUMBAR. Hips R L B R L B LUMBAR. Hips R L B R L B

New England Pain Management Consultants At New England Baptist Hospital

How To Find Out If A Diabetic Woman Has A Urinary Tract Infection

Other Noninfectious Diseases. Chapter 31 Lesson 3

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.

Diabetes Trends in the U.S.: Results from the National Health and Wellness Survey. White Paper. by Kathy Annunziata and Nikoletta Sternbach

Feline Lower Urinary Tract Disease (FLUTD)

Testosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.

TERMS FOR UNDERSTANDING YOUR TYPE 2 DIABETES. Definitions for Common Terms Related to Type 2 Diabetes

Transcription:

Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2014; 2(6A):1973-1977 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources) www.saspublisher.com ISSN 2320-6691 (Online) ISSN 2347-954X (Print) Research Article Clinical Profile of Peripheral Neuropathy in Diabetes Mellitus by Nerve Conduction Study Abhijeet A. Adgaonkar 1*, Anant A. Dawange 2, Shalaka A. Adgaonkar 3, V.G.Kale 4, Pravin P.Shekokar 5 1 Assistant Professor, Department of Medicine, Government Medical College, Akola (M.S.), India 2 Assistant Professor, Department of Surgery, Government Medical College, Akola (M.S.), India 3 Medical officer, District Women s Hospital, Akola (M.S.), India 4 Associate Professor, Department of Medicine, Mahatma Gandhi Missions Medical College, Aurangabad (M.S.), India 5 Assistant Professor, Department of Physiology, Government Medical College, Akola (M.S.), India *Corresponding author Dr. Abhijeet A. Adgaonkar Email: Abstract: Nerve damage or diabetic neuropathy resulting from chronically high blood glucose can be one of the most frustrating and debilitating complications of diabetes because of the pain, discomfort and disability it can cause, and because available treatments are not uniformly successful. The present study comprises study of profile peripheral neuropathy in 50 patients of diabetes mellitus clinically as well as by nerve conduction study. In the present study, the incidence of peripheral neuropathy was recorded as 30% on clinical examinations. Whereas on nerve conduction study it was found 42 %. The most frequent complaint detected in the present study was tingling and numbness. Type 2 diabetes is the most common cause of chronic peripheral neuropathy. Diabetes is more common in people who are overweight or obese. Therefore weight control may help to reduce risk of developing diabetes. Good control of the condition may help to prevent neuropathy from developing. Keywords: Peripheral neuropathy, Diabetes, Nerve conduction INTRODUCTION Peripheral neuropathy is a term which describes damage to peripheral nerves. There are many different conditions that can lead to peripheral neuropathy. Diabetes is the most common cause of persistent (chronic) peripheral neuropathy. The symptoms of peripheral neuropathy depend on which type of peripheral nerves are damaged (sensory, motor or autonomic nerves) [1]. Neuropathy can affect any one, or a combination of all three types of nerves. Peripheral neuropathy in diabetics is nerve damage caused by chronically high blood sugar. It leads to numbness, loss of sensation, and sometimes pain in feet, legs, or hands [2]. About 60% to 70% of all people with diabetes eventually develop peripheral neuropathy, but not all suffer pain. Yet this nerve damage is not inevitable. People with diabetes can reduce their risk of developing nerve damage by keeping their blood sugar levels as close to normal as possible [3]. The treatment for peripheral neuropathy aims to treat any underlying cause, to control your symptoms and to help to achieve maximum independence. Investigations may include various blood tests, X-rays, scans, or other tests. Common tests are include Nerve conduction testing and Electromyography. The nerve conduction test looks at the speed that electrical signals pass through the nerves [1]. Aims and Objectives The study was undertaken to study. Profile of peripheral neuropathy in diabetes mellitus. Correlation of diabetic peripheral neuropathy with various epidemiological factors. Assessment of severity of peripheral neuropathy clinically as well as by nerve conduction study MATERIALS AND METHODS The present study comprises study of profile of peripheral neuropathy in 50 patients of diabetes mellitus, attending indoor and outdoor departments of Mahatma Gandhi Missions College and hospital, Aurangabad from April 2003 to June 2005.These cases include patients of both sex and different age group ranging from 20 to 70 years. They had varying duration of diabetes mellitus. Diagnosis of peripheral neuropathy was made by symptoms, signs. A detailed history was taken in each case. The patients were particularly 1973

questioned to rule out factors which may cause peripheral neuropathy e.g. alcoholism, metallic poisoning, Hensen s diseases, deficiency conditions, syphillis and malignancy. Diabetic patients having obvious liver disease, malignancy, leprosy and patients having clinical evidence of renal involvement were excluded. Patients with a history of taking alcohol, ayurvedic medicine and drugs like INH were excluded from study. The physical examination was carried out in details as in proforma. Clinical peripheral neuropathy was excluded using questionnaire. On neuropathy, the calculation was done as absent (0) & present (1). The calculation of peripheral neuropathy disability score were determined by presence of DTR (Deep Tendon Reflex) (1) decreased DTR & (2) absent DTR sensations. Vibration perception was tested by tuning fork (128 Hz) on each medial malleolus. Pain sensations by pinprick touch sensation with wisp of cotton, temperature sensation by hot and cold water, position sense & DTR were also tested conventionally. In this study peripheral neuropathy was diagnosed clinically with one or two of abnormalities of NSS & NDS. The following was the criteria for detection of peripheral neuropathy by nerve conduction study and the peripheral neuropathy were graded as mild, moderate and severe. The nerves tested are median, peroneal and sural. Hemoglobin estimation, TLC, differential count, Peripheral smear, Urine sugar and ketones, Kidney functions tests, LFT, ECG was done as per needed. The criteria taken for diabetes mellitus are fasting > 110mg% and post meal > 140mg%. Table 1: Criteria taken for Nerve conduction study in study group Nerve Mild Moderate Severe (Ms -1) (Ms -1 ) (Ms -1 ) Median (M) 45-49 2-4 40-45 1-2 <40 <1 NR = 49 NR=4 Median (M) 50-54 10-12 46-50 8-10 <46 <6 NR = 54 NR = 13 Peroneal (M) 40-42 1-2 36-40 0.5-1 <36 <0.5 NR = 42 NR = 2 Sural (S) 40-42 0.5-1 36-40 0.2-0.4 <36 <0.2 NR = 43 NR = 1 (NR Normal range) RESULTS Present study was carried out in dept of Medicine Mahatma Gandhi Missions Medical College and hospital, Aurangabad. Total 50 cases of diabetic peripheral neuropathy were studied. Table 2: Age and sex-wise distribution of study population Age Male Female Total 21-30 03 07 10 31-40 03 02 05 41-50 13 05 18 51-60 08 03 11 61 03 03 06 It is evident from above table that majority of cases diabetes mellitus was in age group 41-50 years. Total of cases include 30 males & 20 females with 1.5:1 ratio. Table 3: Conduction study (Age and Sex-wise) distribution Age (Yrs) Total cases Total Male Female (%) neuropathies 21-30 10 01 -- 01 10.0 31-40 05 01 -- 01 20.0 41-50 18 08 05 03 44.4 51-60 11 10 07 03 90.9 61-70 06 01 01 -- 16.6 Total (%) 50 21 (42%) 13 (43%) 08 (40.0%) 42.0% The above table shows, incidence of peripheral neuropathy as 42% (as compared to 30% on clinical examination). Maximum incidence was recorded in age group 51 to 60 years (90.9%). Clinical examination did not reveal evidence of 1974

peripheral neuropathy in age group of 20 to 30 years. On nerve conduction the incidence of neuropathy in male i.e. 43% over female (40%) was found. Duration of Diabetes mellitus in Yrs Table 4: Correlation of symptomatology of peripheral neuropathy with duration of diabetes Total Total Cases of Total Males showing Total females showing cases neuropathies peripheral neuropathy peripheral neuropathy 1 08 -- -- -- -- 2 08 01 -- 01 12.5 3 09 03 01 02 33.3 4 07 02 01 01 28.5 5 03 01 01 -- 33.3 6 06 05 04 01 83.3 >6 09 09 06 03 100.0 50 21 13 08 42.2 Maximum incidence was noted with duration >6 years. Males have predominance as compared to females. Table 5: Correlation of symptomatic peripheral neuropathy with blood sugar levels Blood Sugar Total cases Total cases of Male Females (%) neuropathies 120-180 03 -- -- -- -- 180-200 10 02 01 01 20.0 200-230 12 04 02 02 33.3 230-260 10 05 03 02 50.0 260-300 09 06 04 02 66.6 >300 06 04 03 01 66.6 50 21 13 08 42.0 Maximum incidence of peripheral neuropathy was noted in blood sugar >300 mg%. Below 200 mg% no patient was symptomatic. Clinical symptoms of peripheral neuropathy are directly proportional to blood sugar levels. Duration (in Years) Table 6: Common clinical features and signs Mild Moderate Severe Total 3 -- 01 -- 01 4 01 -- -- 01 5 -- 01 -- 01 6 -- 03 01 04 >6 -- 01 05 06 Common mode of diabetic peripheral neuropathy is tingling and numbness which was found in 15 cases (30%) followed by impaired vibration 13(26%), impaired ankle jerk (24%), impaired touching (18%) and pain in 8 (16%). Table 7: Showing correlation of blood sugar level with severity of peripheral neuropathy in male patients Blood Sugar Mild Moderate Severity Total 180-200 01 -- -- 01 200-230 -- 02 -- 02 230-260 -- 03 -- 03 260-300 -- 01 03 04 >300 -- -- 03 03 In this study, above table shows that, in male patient as the blood sugar level rises, severity of peripheral neuropathy increases. (%) 1975

Table 8: Showing correlation of duration of diabetes mellitus in female patients with severity of peripheral neuropathy according to nerve conduction study Years Mild Moderate Severity Total 2 01 -- -- 01 3 -- 02 -- 02 4 -- 01 -- 01 5 -- -- --- -- 6 -- 01 -- 01 >6 -- -- 03 03 In the present study, as the duration of diabetes mellitus increases the severity of peripheral neuropathy increase in females. Table 9: Showing correlation of diabetic status with severity of peripheral neuropathy in female patients Blood Sugar Mild Moderate Severity Total 180-200 01 -- -- 01 200-230 -- 02 -- 02 230-260 -- 02 -- 02 260-300 -- -- 02 02 >300 -- -- 01 01 Above table shows that, in female patient as the blood sugar level rises, severity of peripheral neuropathy increases. DISCUSSION In the present study, out of 50 cases studied, 30 were males & 20 were females. The age of patient varies from 21 to 70 years; maximum patients were in age group of 51 to 70 years. Clinical incidence In the present study, incidence of peripheral neuropathy was found to be 30% on clinical examination, the figure tallies with Kuruvilla et al. [4]. The variability may depend upon selection of cases, high age group, longer duration and severity of diabetes. Age incidence The diabetic neuropathy is commonest after 5 th decade. Bhal et al. [5] demonstrated that middle age/elderly diabetic were generally more affected. Shaw et al. [6] showed incidence of peripheral neuropathy was 17.6% between age group of 20-40 years and 56.8% between 40-70 years. Kasturi et al. [7] successfully done study on 100 patients and found incidence of peripheral neuropathy. Incidence of neuropathy was more in patients over 40 years of age (60 out of 70 patients) with duration of disease over two years (78.33 percent). Thus it is common that peripheral neuropathy in general was common in middle age and elderly diabetics. It can sometimes occur in younger diabetic and may be absent in older diabetics. Blood Sugar levels:- Maximum patients have peripheral blood sugar levels of fasting 200 to 220 & post meal 280-300 mg%. Partanen et al. [8] demonstrated rising incidence of peripheral neuropathy with crease of blood sugar levels. Dutta et al. [9] found incidence of peripheral neuropathy with blood sugar level in lower range. In the present study it was observed that severity of peripheral neuropathy was related with blood sugar. Higher the blood sugar level, severe is the neuropathy. Thus it can be concluded that peripheral neuropathy is common in diabetic & who has higher blood sugar levels. However the patients with lower blood sugar level have decreased incidence of peripheral neuropathy. Duration of diabetes mellitus In the present study neurological involvement were noted in relation to duration of diabetes mellitus. Kasturi et al. [7] also found the positive correlation between duration of diabetes mellitus and incidence of peripheral neuropathy. Present study very well matched with workers like Shaw et al. [6] and Kasturi et al. [7]. Severity of peripheral neuropathy by nerve conduction study Through the criteria for defining the severity of disease were slightly different by various authors. However the study of Parati [10] and Biju Paul [11] were comparable with present study. They found direct positive relation of the incidence of peripheral neuropathy with the blood sugar and the duration of diabetes mellitus by nerve conduction study. Parati [10] very well concluded that, as the blood sugar level increases above 260 mg%, the conduction 1976

velocity and amplitude of sensory and motor nerve decreases. Similarly Biju Paul [11] concluded that there is inverse relation of the duration of diabetes mellitus with the velocity and amplitude of the various nerves (sensory and motor by nerve conduction study). Present study also shows the findings which matches with the above mentioned authors. Present study also showed that as the duration of diabetes of diabetes mellitus increases more than 5 years and as the blood sugar levels increases > 260 mg%, the velocity and amplitude of nerves decreases. Patterns of presentation of diabetic neuropathies: Patients with peripheral neuropathy show sensory involvement predominantly. It was observed in every case of peripheral neuropathy. Clinically patients showed signs of mixed sensory and motor involvement in the form of paresthesia and sensory loss together with diminished power and absent or diminished ankle jerk. No case of pure motor involvement was found in present study. Diabetic peripheral sensory motor peripheral neuropathy was the commonest type of presentation in present study. The lower limbs were almost always affected. The upper limbs were less affected. However, the upper limb was involved in 18 out of 21 cases. There are 6 cases, which do not show any symptom and signs of peripheral neuropathy. However they are detected on nerve conduction study. In our study, no mononeuritis multiplex patient was observed. CONCLUSION In the present study, the incidence of peripheral neuropathy was recorded as 30% on clinical examinations. Whereas on nerve conduction study it was found to be 42 %. The most frequent complaint detected in the present study was tingling and numbness. The most frequent signs detected were impaired sense of vibration, impaired sensation, loss the ankle jerk. On clinical examination, incidence of peripheral neuropathy in males was found to be 33% and in females it is 25% on clinical examinations where as on nerve conduction study it was 43% in male and 40% female. Not a single case was observed in age group 21-30 yrs. As the age increases, severity of peripheral neuropathy increases. It is observed that, as duration of diabetes mellitus increases, the severity of peripheral neuropathy increases, with the increase of blood sugar, more cases of peripheral neuropathy were detected clinically. The severity of peripheral neuropathy was found to be a directly related with the levels of blood sugar i.e. blood sugar >300mg. In severe form of diabetic according to blood sugar is blood sugar i.e. > 300 mg. Nerve conduction study was not of much significance because in this clinical incidence of neuropathy is obvious. From the present study it is concluded that nerve conduction study was of significant importance in detecting mild to mod form of peripheral neuropathy which is missed on only by clinical examination. REFERENCES 1. Peripheral Neuropathy. Available from http://www.patient.co.uk/health/peripheralneuropathy-leaflet 2. Diabetic neuropathy and low carbs. Available from http://forum.lowcarber.org/archive/index.php/t -198692.html 3. Peripheral Neuropathy and Diabetes. Available from http://www.drstevenjdolgoff.com/diabetic_peri pheral_neuropathy_described_by_dr_steven_j _dolgoff.html 4. Kurivilla N; Thesis for M.D., Vellore, 1970. 5. Bahl A, Khosla HL, Caroli RK; A study of the involvement of the nervous system with special reference to neuropathy in diabetes mellitus. Indian Med Gaz., 1967; 24: 53. 6. Shaw JE, Hodge AM, decoruten M, Dowse GK, Gareeboo H, Tuomilehto J et al.; Diabetic peripheral neuropathy in Mauritius: Prevalence and risk factors. Diabetes Res Clin Pract., 1998; 43(2): 131-139. 7. Kasthuri AS, Sofat MS, Kumar CN; Somatic Neuropathy in Diabetes Mellitus. MJAFI, 2000; 56: 33-36. 8. Partanen J, Niskanen L, Lehtinen J, Mervaala E; Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. New Engl J Med., 1995; 333(2): 89-94. 9. Dutta A, Naorem S, Singh TP, Wangjam K; Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics. Int J Diab Dev Countries, 2005; 25: 30-33. 10. Parati NL; Neuropathies in diabetes mellitus with special reference to autonomic peripheral neuropathy. Dissertation for M.D., 1979. 11. Paul B; Peripheral neuropathy. Dissertation for M.D., 1994. 1977